Soleus Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.2M Sell
497,706
-531,546
-52% -$25.8M 0.72% 34
2026
Q2
$53.9M Sell
1,029,252
-941,612
-48% -$36.8M 1.86% 14
2026
Q1
$69.7M Buy
1,970,864
+648,500
+49% +$20.1M 2.82% 9
2025
Q4
$37M Buy
+1,322,364
New +$39.6M 1.36% 20
2023
Q4
– Sell
-54,400
Closed -$1.52M – 75
2023
Q3
$1.52M Sell
54,400
-140,000
-72% -$4.1M 0.14% 74
2023
Q2
$6.08M Sell
194,400
-35,600
-15% -$1.08M 0.68% 43
2023
Q1
$6.48M Buy
+230,000
New +$6.27M 0.67% 43

Other funds holding ALKS

Soleus Capital Management's ALKS Position: Q3 2026 in Review

Soleus Capital Management reduced its Alkermes (ALKS) stake by 52% in Q3 2026, selling an estimated $25.8M and leaving 497,706 shares worth $20.2M. The position accounts for 0.72% of the portfolio, ranked #34.

Soleus Capital Management first reported a position in ALKS in Q1 2023 and has held it in 7 quarters since. The position peaked at $69.7M in Q1 2026. 417 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Soleus Capital Management held 497,706 shares of Alkermes worth $20.2M as of Q3 2026.
  • Soleus Capital Management sold 531,546 Alkermes shares in Q3 2026, an estimated $25.8M.
  • Alkermes made up 0.72% of Soleus Capital Management's portfolio in Q3 2026, its #34 holding.
  • Soleus Capital Management first reported a position in Alkermes in Q1 2023 and has held it in 7 quarters since.
  • Soleus Capital Management's Alkermes position peaked at $69.7M in Q1 2026.
  • 417 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.